SKVIOTCPharmaceutical PreparationsFiscal year ends December 31
SKINVISIBLE, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.16+0.00 (+0.06%)
Close on Oct 19, 2026
- Market cap
- $843.54K
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.2439 (−60.98%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
SKINVISIBLE, INC. grew revenue 0.0% to $20.00K over the twelve months to Jun 30, 2026. Free cash flow was -$42.50K.
Revenue
$20.00K
0.0% vs. a year earlier
Operating income
-$458.98K
TTM Q2 2026
Free cash flow
-$42.50K
FY2025
EPS, diluted
-$0.20
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $843.54K
- P/E ratio
- –
- Price to sales
- 42.18
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- -5.04%
Fundamentals
- Revenue
- $20.00K
- Net income
- -$1.03M
- EPS, diluted
- -$0.20
- Free cash flow
- -$42.50K
- Book value per share
- -$2.00
- Diluted shares
- 5M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$20.00K0.0% YoY
Gross profit
$20.00K0.0% YoY
Operating income
-$458.98K
Net income
-$1.03M
EPS, diluted
-$0.20
Free cash flow
–
Reported periodTrailing twelve months